Viewing Study NCT00451295


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2025-12-27 @ 9:13 PM
Study NCT ID: NCT00451295
Status: TERMINATED
Last Update Posted: 2011-11-15
First Post: 2007-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
Sponsor: Tanabe Pharma Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module